Aquestive Therapeutics announced it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for Anaphylm (dibutepinephrine) Sublingual Film, a noninvasive ...
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European UnionARS Pharma’s partner, ...
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ...
Aquestive Therapeutics said on Monday the U.S. FDA has declined to approve its oral drug for severe allergic reactions due to packaging issues, marking a setback to its efforts to enter the allergy ...
Ward 5 Coun. Matthew Scott and Ward 3's Angela Caputo want EpiPen auto-injectors to be as easily accessible as naloxone or ...
Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional ...
Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
The following is a summary of a story on the Student Experience website. Seth and Susan Lee’s son, Jacob, is a Duke undergrad set to graduate in May. Jacob has lived with life-threatening nut and seed ...
I love a peanut butter and tuna sandwich. But when I was a kid, my school outlawed peanuts. My classmate was super allergic to them. So, we had a rule to keep our friend safe. I packed plain tuna fish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results